JW Shinyak Corp operates in the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares JW Shinyak Corp with three other
companies in this sector in South Korea:
Binex Company Ltd
sales of 78.03 billion Korean Won [US$73.27 million]
of which 83%
Dongsung Pharmaceutical Company Limited
(82.39 billion Korean Won [US$77.36 million]
of which 92%
was Pharmaceutical Segment), and
Wooridul Pharmaceutical Limited
(79.89 billion Korean Won [US$75.02 million]
of which 100%
JW Shinyak Corp reported sales of 76.84 billion Korean Won (US$72.16 million)
December of 2017.
decrease of 7.8%
versus 2016, when the company's sales were 83.38 billion Korean Won.
The sales level in 2017 was fairly close to the level five years ago: in 2012, JW Shinyak Corp had sales
of 69.92 billion Korean Won.